Aeglea BioTherapeutics, Inc. (AGLE) earnings
Quarterly and annual AGLE reports and results, each read against the price at its own news timestamp. Back to the AGLE overview →
2 measured AGLE earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Aeglea BioTherapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update | Press release | +0.00% | +2.82% | |
| Form 10-Q Aeglea BioTherapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +2.82% |
Keep exploring
More AGLE: analyst actions → · SEC filings → · AGLE overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| RYMAN HEALTHCARE UNSP/ADR (RYHTY) | 39 | 0.00% | 0% |
| Acer Therapeutics Inc. (ACER) | 38 | -1.46% | 23% |
| Bellicum Pharmaceuticals, Inc. (BLCM) | 38 | 0.00% | 29% |
| Medx Health Corp (MDX_CDNX) | 38 | 0.00% | 38% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.